e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Markers and triggers of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A case of laryngo-tracheal amyloidosis, evaluated as refractory asthma
L. Pur Ozyigit, A. Yakar, G. Okumus, E. Kiyan (Istanbul, Turkey)
Source:
Annual Congress 2008 - Markers and triggers of asthma
Session:
Markers and triggers of asthma
Session type:
Thematic Poster Session
Number:
484
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Pur Ozyigit, A. Yakar, G. Okumus, E. Kiyan (Istanbul, Turkey). A case of laryngo-tracheal amyloidosis, evaluated as refractory asthma. Eur Respir J 2008; 32: Suppl. 52, 484
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Super-response to dupilumab therapy in a patient with severe asthma and ABPA – a case report
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Oropharyngeal swallowing pathophysiology in patients with idiopathic pulmonary fibrosis: A consecutive descriptive case series.
Source: Virtual Congress 2020 – Imaging evaluation of chronic lung diseases
Year: 2020
Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre
Source: ERJ Open Res, 7 (1) 00170-2020; 10.1183/23120541.00170-2020
Year: 2021
Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 829s
Year: 2006
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?
Source: Eur Respir J 2003; 22: 8-13
Year: 2003
Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
A rare case of idiopathic pulmonary fibrosis in children
Source: Eur Respir J 2007; 30: Suppl. 51, 390s
Year: 2007
Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia
Source: Eur Respir J 2013; 41: 402-409
Year: 2013
Effect of ABPA treatment in severe asthma patients with acute and relapsed disease
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Progressive case of recurrent respiratory papillomatosis successfully treated with gefitinib
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Prevalence of adrenal insufficiency in patients started on Mepolizumab for severe eosinophilic asthma.
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012
Recurrent eosinophilic pneumonia in an asthmatic patient treated with sequential montelukast/zafirlukast after corticosteroid withdrawal
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002
Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Clinical features of steroid-resistant patients with severe steroid-dependent bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 133s
Year: 2004
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept